dpp-4 inhibitors and glp-1 agonists together Mechanism of action for GIP, analogues DPP4 in Comparison of GLP-1 receptor agonists

Long non-Coding RNA lnc-CCNL1-3:1 Promotes Granulosa Cell Apoptosis and Suppresses Glucose Uptake in Women With Polycystic Ovary Syndrome

GLP-1 receptor agonists reduce inflammation in the brain and the protein-deposit changes characteristic of Alzheimer's disease in animal models, and early-stage clinical trials of older drugs in the same class have produced suggestions of preservation of cognitive function in mild memory and thinking problems and in Parkinson's disease, although large-scale confirmation is still not there [13]

Dont see any difference after 6 weeks

Seeking advice from a qualified healthcare professional helps ensure that any treatment plan is appropriate for your individual health needs and is supported by current medical evidence